K. Syrj�nen

834 citations
20 papers · 705 indexed · h-index 14

K. Syrj�nen

20 papers receiving 671 citations

Peers

K. Syrj�nen
Comparison fields: 5 of 68
  • Otorhinolaryngology 87
  • Periodontics 66
  • Epidemiology 383
  • Oncology 269
  • Cancer Research 124
Replace Magdolna Bollmann with:
Magdolna Bollmann Germany
Gordana Halec Germany
T. Löning Germany
M. Menton Germany
R. J. Kurman United States
Carla Ferrándiz‐Pulido Spain
Cláudio Osmar Pereira Alexandre Brazil
Christine Carreira France
Lori A. Kelly United States
K. Syrj�nen relative to Magdolna Bollmann Germany Magdolna Bollmann's profile →
Citations per field
00.5×2.6×
Magdolna Bollmann · 1×
Citations per year

Countries citing papers authored by K. Syrj�nen

Since Specialization
Citations

This map shows the geographic impact of K. Syrj�nen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Syrj�nen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Syrj�nen more than expected).

Fields of papers citing papers by K. Syrj�nen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Syrj�nen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Syrj�nen. The network helps show where K. Syrj�nen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside K. Syrj�nen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Syrj�nen Line = papers co-authored together K. Syrj�nen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2000133
2 199956
3 19979
4 199611
5 199645
6 19959
7 199415
8 199324
9 199243
10 199041
11 199070
12 198961
13 198819
14 19887
15 198756
16 198417
17 198438
18 19824
19 198143
20 19804

About K. Syrj�nen

K. Syrj�nen is a scholar working on Periodontics, Cancer Research, Microbiology, Oral Surgery and Oncology, having authored 20 papers that have together received 705 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (6 papers), Oral Health Pathology and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers), Virus-based gene therapy research (2 papers), Cancer and Skin Lesions (2 papers), Reproductive tract infections research (2 papers), Oral and Maxillofacial Pathology (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Otorhinolaryngology (87 citations), Periodontics (66 citations), Epidemiology (383 citations), Oncology (269 citations) and Cancer Research (124 citations). K. Syrj�nen has collaborated with scholars based in Finland, Germany and France. Frequent co-authors include Matti A. Lamberg, S. Partanen, Fuju Chang, P. Lipponen, Merja Yliskoski, Jari Nuutinen, S. Aaltomaa, R.‐P. Happonen, Anthony B. Miller and Vesa Kataja. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Archives of Dermatological Research, International Journal of Cancer, Archives of Gynecology and Obstetrics and European Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026